What is Sylvamo's operating income?

Sylvamo's total operating income in 2025 was $238 million, based on the following breakdown: Total Gross Profit: $735 million Total Operating Expenses: $497 million

Sylvamo (SLVM) Financials

$36.71 -0.20 (-0.54%)

As of 01:58 PM Eastern

Compare

Annual Income Statements for Sylvamo

This table shows Sylvamo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	377	170	331	118	253	302	132
Consolidated Net Income / (Loss)	377	170	331	118	253	302	132
Net Income / (Loss) Continuing Operations	377	87	227	336	253	302	132
Total Pre-Tax Income	502	95	328	467	369	405	199
Total Operating Income	493	91	327	536	403	444	238
Total Gross Profit	1,379	456	685	1,009	912	940	735
Total Revenue	4,017	2,385	2,828	3,628	3,721	3,773	3,351
Operating Revenue	4,017	2,385	2,828	3,628	3,721	3,773	3,351
Total Cost of Revenue	2,638	1,929	2,143	2,619	2,809	2,833	2,616
Operating Cost of Revenue	2,638	1,929	2,143	2,619	2,809	2,833	2,616
Total Operating Expenses	886	365	358	473	509	496	497
Selling, General & Admin Expense	655	202	207	325	343	311	281
Depreciation Expense	192	135	126	125	143	159	179
Other Operating Expenses / (Income)	33	28	25	23	23	26	26
Impairment Charge	-	-	-	-	0.00	0.00	11
Total Other Income / (Expense), net	9.00	4.00	1.00	-69	-34	-39	-39
Interest Expense	-9.00	-4.00	-1.00	69	34	39	39
Income Tax Expense	125	8.00	101	131	116	103	67
Basic Earnings per Share	$8.55	$3.85	$7.53	$2.68	$6.02	$7.35	$3.29
Weighted Average Basic Shares Outstanding	-	-	43.96M	42.37M	41.22M	40.55M	39.51M
Diluted Earnings per Share	$8.55	$3.85	$7.53	$2.66	$5.93	$7.18	$3.24
Weighted Average Diluted Shares Outstanding	-	-	43.96M	42.37M	41.22M	40.55M	39.51M
Weighted Average Basic & Diluted Shares Outstanding	-	-	43.96M	42.37M	41.22M	40.55M	39.51M
Cash Dividends to Common per Share	-	-	-	$0.48	$1.40	$1.65	$1.80

This table shows Sylvamo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	49	43	83	95	81	27	15	57	33	-3.00	-11
Consolidated Net Income / (Loss)	49	43	83	95	81	27	15	57	33	-3.00	-11
Net Income / (Loss) Continuing Operations	49	43	83	95	81	27	15	57	33	-3.00	-11
Total Pre-Tax Income	67	60	113	132	100	33	20	88	58	-6.00	1.00
Total Operating Income	73	69	122	146	107	42	30	97	69	3.00	12
Total Gross Profit	211	189	249	265	237	159	154	222	200	125	132
Total Revenue	964	905	933	965	970	821	794	846	890	755	806
Operating Revenue	964	905	933	965	970	821	794	846	890	755	806
Total Cost of Revenue	753	716	684	700	733	662	640	624	690	630	674
Operating Cost of Revenue	753	716	684	700	733	662	640	624	690	630	674
Total Operating Expenses	138	120	127	119	130	117	124	125	131	122	120
Selling, General & Admin Expense	96	74	82	74	81	73	72	68	68	73	69
Depreciation Expense	38	39	37	39	44	40	45	49	45	41	43
Other Operating Expenses / (Income)	4.00	7.00	8.00	6.00	5.00	4.00	7.00	8.00	7.00	8.00	8.00
Total Other Income / (Expense), net	-6.00	-9.00	-9.00	-14	-7.00	-9.00	-10	-9.00	-11	-9.00	-11
Interest Expense	6.00	9.00	9.00	14	7.00	9.00	10	9.00	11	9.00	11
Income Tax Expense	18	17	30	37	19	6.00	5.00	31	25	-3.00	12
Basic Earnings per Share	$1.19	$1.04	$2.02	$2.32	$1.97	$0.66	$0.37	$1.43	$0.83	($0.08)	($0.28)
Weighted Average Basic Shares Outstanding	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M	39.76M
Diluted Earnings per Share	$1.17	$1.02	$1.98	$2.27	$1.91	$0.65	$0.37	$1.41	$0.81	($0.08)	($0.28)
Weighted Average Diluted Shares Outstanding	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M	39.76M
Weighted Average Basic & Diluted Shares Outstanding	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M	39.76M

This table details how cash moves in and out of Sylvamo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-40	-40	89	201	-80	-75	-70
Net Cash From Operating Activities	524	359	549	438	504	469	268
Net Cash From Continuing Operating Activities	524	245	423	418	504	469	268
Net Income / (Loss) Continuing Operations	377	87	227	336	253	302	132
Consolidated Net Income / (Loss)	377	-	-	-	253	302	132
Depreciation Expense	192	135	126	125	143	159	179
Non-Cash Adjustments To Reconcile Net Income	19	36	14	41	23	23	29
Changes in Operating Assets and Liabilities, net	-64	-11	56	-63	85	-15	-72
Net Cash From Investing Activities	-160	-79	127	180	-377	-221	-224
Net Cash From Continuing Investing Activities	-160	-68	113	185	-377	-221	-224
Purchase of Property, Plant & Equipment	-118	-66	-69	-149	-210	-221	-224
Acquisitions	-	-	0.00	0.00	-167	0.00	0.00
Net Cash From Financing Activities	-387	-350	-589	-470	-219	-310	-125
Net Cash From Continuing Financing Activities	-387	-350	-588	-469	-219	-310	-125
Repayment of Debt	-18	-10	-113	-454	-538	-429	-199
Repurchase of Common Equity	-	0.00	0.00	-80	-70	-69	-82
Payment of Dividends	-	0.00	0.00	-10	-57	-62	-73
Issuance of Debt	0.00	0.00	1,501	75	446	250	229
Effect of Exchange Rate Changes	-17	30	-2.00	32	12	-13	11

This table details how cash moves in and out of Sylvamo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	26	-71	-4.00	103	-103	-51	-41	-19	41	-5.00	-7.00
Net Cash From Operating Activities	167	27	115	163	164	23	64	87	94	-10	38
Net Cash From Continuing Operating Activities	167	27	115	163	164	23	64	87	94	-10	38
Net Income / (Loss) Continuing Operations	49	43	83	95	81	27	15	57	33	-3.00	-11
Consolidated Net Income / (Loss)	-	43	83	95	-	27	15	57	33	-3.00	-11
Depreciation Expense	38	39	37	39	44	40	45	49	45	41	43
Non-Cash Adjustments To Reconcile Net Income	2.00	7.00	5.00	5.00	6.00	6.00	7.00	4.00	12	-16	2.00
Changes in Operating Assets and Liabilities, net	78	-62	-10	24	33	-50	-3.00	-23	4.00	-32	4.00
Net Cash From Investing Activities	-63	-60	-53	-44	-64	-48	-66	-54	-56	-49	-60
Net Cash From Continuing Investing Activities	-63	-60	-53	-44	-64	-48	-66	-54	-56	-49	-60
Purchase of Property, Plant & Equipment	-63	-60	-53	-44	-64	-48	-66	-54	-56	-49	-61
Net Cash From Financing Activities	-88	-35	-60	-19	-196	-31	-45	-52	3.00	53	15
Net Cash From Continuing Financing Activities	-88	-35	-60	-19	-196	-31	-45	-52	3.00	53	15
Repayment of Debt	-49	-24	-32	-235	-138	-16	-32	-10	-141	-43	-424
Payment of Dividends	-25	-12	-13	-18	-19	-18	-18	-19	-18	-18	-18
Issuance of Debt	3.00	6.00	10	234	-	23	25	19	162	114	457

This table presents Sylvamo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	2,911	2,597	2,710	2,872	2,604	2,763
Total Current Assets	1,119	1,108	1,243	1,193	1,063	1,076
Cash & Equivalents	95	159	360	220	205	135
Note & Lease Receivable	621	402	450	428	429	424
Inventories, net	342	279	364	404	361	418
Other Current Assets	61	89	69	81	68	99
Plant, Property, & Equipment, net	0.00	0.00	817	0.00	0.00	0.00
Total Noncurrent Assets	1,792	1,489	650	1,679	1,541	1,687
Goodwill	143	122	128	139	111	114
Other Noncurrent Operating Assets	1,649	1,226	522	1,540	1,430	1,573
Total Liabilities & Shareholders' Equity	2,911	2,597	2,710	2,872	2,604	2,763
Total Liabilities	799	2,415	2,032	1,971	1,757	1,797
Total Current Liabilities	490	758	728	695	682	716
Short-Term Debt	4.00	41	29	28	22	90
Accounts Payable	284	387	453	421	375	381
Current Employee Benefit Liabilities	68	48	81	63	79	55
Other Current Liabilities	134	191	165	183	206	190
Total Noncurrent Liabilities	309	1,657	1,304	1,276	1,075	1,081
Long-Term Debt	22	1,357	1,003	931	782	763
Noncurrent Deferred & Payable Income Tax Liabilities	170	169	183	189	152	175
Other Noncurrent Operating Liabilities	117	118	118	156	141	143
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,112	182	678	901	847	966
Total Preferred & Common Equity	2,112	182	678	901	847	966
Total Common Equity	2,112	182	678	901	847	966
Common Stock	0.00	48	69	93	116	135
Retained Earnings	0.00	1,935	2,029	2,222	2,455	2,514
Treasury Stock	-	0.00	-82	-	-234	-330
Accumulated Other Comprehensive Income / (Loss)	-1,480	-1,801	-1,338	-1,256	-1,490	-1,353

This table presents Sylvamo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	2,798	2,823	2,785	2,797	2,691	2,861	2,629	2,668	2,703	2,834	2,875
Total Current Assets	1,209	1,161	1,186	1,115	1,100	1,229	1,011	977	990	1,097	1,107
Cash & Equivalents	191	164	194	149	145	248	154	113	94	130	123
Note & Lease Receivable	441	440	423	413	411	439	416	383	393	378	366
Inventories, net	506	486	456	407	412	421	372	396	434	483	503
Other Current Assets	71	71	53	86	72	61	69	85	69	106	115
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	1,589	1,662	1,599	1,682	1,591	1,632	1,618	1,691	1,713	1,737	1,768
Goodwill	133	140	134	134	121	125	119	126	128	121	121
Other Noncurrent Operating Assets	1,456	1,522	1,465	1,548	1,470	1,507	1,499	1,565	1,585	1,616	1,647
Total Liabilities & Shareholders' Equity	2,798	2,823	2,785	2,797	2,691	2,861	2,629	2,668	2,703	2,834	2,875
Total Liabilities	2,008	1,961	1,949	1,908	1,861	1,924	1,721	1,709	1,726	1,855	1,920
Total Current Liabilities	726	667	674	649	654	714	616	635	653	758	752
Short-Term Debt	104	79	53	28	28	43	23	46	30	155	121
Accounts Payable	409	391	382	404	389	381	386	371	383	407	422
Current Employee Benefit Liabilities	53	50	66	52	65	76	52	53	57	56	52
Other Current Liabilities	160	147	173	165	172	214	155	165	183	140	157
Total Noncurrent Liabilities	1,282	1,294	1,275	1,259	1,207	1,210	1,105	1,074	1,073	1,097	1,168
Long-Term Debt	954	954	946	921	894	883	794	767	778	766	843
Noncurrent Deferred & Payable Income Tax Liabilities	198	212	202	180	162	164	162	151	148	179	171
Other Noncurrent Operating Liabilities	130	128	127	158	151	163	149	156	147	152	154
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	790	862	836	889	830	937	908	959	977	979	955
Total Preferred & Common Equity	790	862	836	889	830	937	908	959	977	979	955
Total Common Equity	790	862	836	889	830	937	908	959	977	979	955
Common Stock	76	84	90	99	105	110	123	130	134	139	143
Retained Earnings	2,116	2,153	2,185	2,253	2,317	2,393	2,463	2,460	2,499	2,493	2,464
Accumulated Other Comprehensive Income / (Loss)	-1,305	-1,248	-1,298	-1,293	-1,397	-1,371	-1,410	-1,343	-1,326	-1,317	-1,316
Other Equity Adjustments	-97	-127	-	-	-	-	-	-	-	-	-336

This table displays calculated financial ratios and metrics derived from Sylvamo's official financial filings.

Metric	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-
Revenue Growth	0.00%	-40.63%	18.57%	28.29%	2.56%	1.40%	-11.18%
EBITDA Growth	0.00%	-67.01%	100.44%	45.92%	-17.40%	10.44%	-30.85%
EBIT Growth	0.00%	-81.54%	259.34%	63.91%	-24.81%	10.17%	-46.40%
NOPAT Growth	0.00%	-77.49%	171.56%	70.41%	-28.35%	19.82%	-52.32%
Net Income Growth	0.00%	-54.91%	94.71%	-64.35%	114.41%	19.37%	-56.29%
EPS Growth	0.00%	-54.97%	95.58%	-64.67%	122.93%	21.08%	-54.87%
Operating Cash Flow Growth	0.00%	-31.49%	52.92%	-20.22%	15.07%	-6.94%	-42.86%
Free Cash Flow Firm Growth	0.00%	0.00%	154.31%	-77.39%	-80.76%	904.24%	-117.23%
Invested Capital Growth	0.00%	0.00%	-41.02%	12.03%	17.04%	-8.48%	16.46%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	15.25%	1.00%	0.16%	-2.33%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	29.35%	-9.75%	7.10%	-8.15%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	34.34%	-14.07%	8.29%	-13.77%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	44.54%	-14.45%	11.26%	-23.42%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	37.21%	-15.10%	11.85%	-26.67%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-13.81%	11.49%	-25.35%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	7.02%	-6.01%	5.22%	-0.64%	-20.71%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	103.68%	43.73%	-214.24%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-0.06%	-7.01%	-0.41%
Profitability Metrics	-	-	-	-	-	-	-
Gross Margin	34.33%	19.12%	24.22%	27.81%	24.51%	24.91%	21.93%
EBITDA Margin	17.05%	9.48%	16.02%	18.22%	14.67%	15.98%	12.44%
Operating Margin	12.27%	3.82%	11.56%	14.77%	10.83%	11.77%	7.10%
EBIT Margin	12.27%	3.82%	11.56%	14.77%	10.83%	11.77%	7.10%
Profit (Net Income) Margin	9.39%	7.13%	11.70%	3.25%	6.80%	8.00%	3.94%
Tax Burden Percent	75.10%	178.95%	100.91%	25.27%	68.56%	74.57%	66.33%
Interest Burden Percent	101.83%	104.40%	100.31%	87.13%	91.56%	91.22%	83.61%
Effective Tax Rate	24.90%	8.42%	30.79%	28.05%	31.44%	25.43%	33.67%
Return on Invested Capital (ROIC)	0.00%	8.16%	13.94%	30.19%	18.86%	21.88%	10.09%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-243.04%	35.88%	-1.39%	15.41%	17.33%	6.16%
Return on Net Nonoperating Assets (RNNOA)	0.00%	7.94%	14.92%	-2.75%	13.18%	12.67%	4.47%
Return on Equity (ROE)	0.00%	16.10%	28.86%	27.44%	32.05%	34.55%	14.56%
Cash Return on Invested Capital (CROIC)	0.00%	-191.84%	65.54%	18.84%	3.16%	30.74%	-5.12%
Operating Return on Assets (OROA)	0.00%	3.13%	11.87%	20.20%	14.44%	16.22%	8.87%
Return on Assets (ROA)	0.00%	5.84%	12.02%	4.45%	9.06%	11.03%	4.92%
Return on Common Equity (ROCE)	0.00%	16.10%	28.86%	27.44%	32.05%	34.55%	14.56%
Return on Equity Simple (ROE_SIMPLE)	0.00%	8.05%	181.87%	17.40%	28.08%	35.66%	0.00%
Net Operating Profit after Tax (NOPAT)	370	83	226	386	276	331	158
NOPAT Margin	9.22%	3.49%	8.00%	10.63%	7.43%	8.78%	4.71%
Net Nonoperating Expense Percent (NNEP)	0.00%	251.20%	-21.95%	31.58%	3.45%	4.55%	3.93%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	22.55%	14.86%	20.05%	8.68%
Cost of Revenue to Revenue	65.67%	80.88%	75.78%	72.19%	75.49%	75.09%	78.07%
SG&A Expenses to Revenue	16.31%	8.47%	7.32%	8.96%	9.22%	8.24%	8.39%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	22.06%	15.30%	12.66%	13.04%	13.68%	13.15%	14.83%
Earnings before Interest and Taxes (EBIT)	493	91	327	536	403	444	238
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	685	226	453	661	546	603	417
Valuation Ratios	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	6.40	2.98	2.20	3.80	1.95
Price to Tangible Book Value (P/TBV)	0.00	0.00	19.42	3.67	2.60	4.38	2.21
Price to Revenue (P/Rev)	0.00	0.00	0.41	0.56	0.53	0.85	0.56
Price to Earnings (P/E)	0.00	0.00	3.52	17.12	7.84	10.67	14.25
Dividend Yield	0.00%	0.00%	0.00%	0.49%	2.20%	1.91%	3.77%
Earnings Yield	0.00%	0.00%	28.41%	5.84%	12.76%	9.37%	7.02%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	2.00	1.99	1.68	2.64	1.54
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.85	0.74	0.72	1.01	0.78
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	5.31	4.07	4.87	6.34	6.23
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	7.35	5.02	6.60	8.61	10.92
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	10.62	6.98	9.63	11.54	16.46
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	4.38	6.15	5.28	8.15	9.70
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	2.26	11.19	57.47	8.22	0.00
Leverage & Solvency	-	-	-	-	-	-	-
Debt to Equity	0.00	0.01	7.68	1.52	1.06	0.95	0.88
Long-Term Debt to Equity	0.00	0.01	7.46	1.48	1.03	0.92	0.79
Financial Leverage	0.00	-0.03	0.42	1.97	0.86	0.73	0.73
Leverage Ratio	0.00	1.38	2.40	6.17	3.54	3.13	2.96
Compound Leverage Factor	0.00	1.44	2.41	5.38	3.24	2.86	2.48
Debt to Total Capital	0.00%	1.22%	88.48%	60.35%	51.56%	48.70%	46.89%
Short-Term Debt to Total Capital	0.00%	0.19%	2.59%	1.70%	1.51%	1.33%	4.95%
Long-Term Debt to Total Capital	0.00%	1.03%	85.89%	58.66%	50.05%	47.37%	41.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	98.78%	11.52%	39.65%	48.44%	51.30%	53.11%
Debt to EBITDA	0.00	0.12	3.09	1.56	1.76	1.33	2.05
Net Debt to EBITDA	0.00	-0.31	2.74	1.02	1.24	0.99	1.72
Long-Term Debt to EBITDA	0.00	0.10	3.00	1.52	1.71	1.30	1.83
Debt to NOPAT	0.00	0.31	6.18	2.68	3.47	2.43	5.40
Net Debt to NOPAT	0.00	-0.83	5.47	1.74	2.46	1.81	4.55
Long-Term Debt to NOPAT	0.00	0.26	6.00	2.60	3.37	2.36	4.83
Altman Z-Score	0.00	0.00	3.00	3.86	3.65	4.61	3.56
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-
Current Ratio	0.00	2.28	1.46	1.71	1.72	1.56	1.50
Quick Ratio	0.00	1.46	0.74	1.11	0.93	0.93	0.78
Cash Flow Metrics	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1,960	1,064	241	46	465	-80
Operating Cash Flow to CapEx	455.65%	543.94%	795.65%	293.96%	240.00%	212.22%	119.64%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	3.49	1.36	11.93	-2.05
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	6.35	14.82	12.03	6.87
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	4.19	8.65	6.36	1.13
Efficiency Ratios	-	-	-	-	-	-	-
Asset Turnover	0.00	0.82	1.03	1.37	1.33	1.38	1.25
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	5.64	6.90	8.15	7.32	7.41	6.72
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	6.79	6.39	6.24	6.43	7.12	6.92
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	64.71	52.89	44.81	49.90	49.28	54.35
Days Payable Outstanding (DPO)	0.00	53.74	57.14	58.53	56.78	51.28	52.74
Cash Conversion Cycle (CCC)	0.00	10.97	-4.26	-13.73	-6.89	-2.00	1.60
Capital & Investment Metrics	-	-	-	-	-	-	-
Invested Capital	0.00	2,043	1,205	1,350	1,580	1,446	1,684
Invested Capital Turnover	0.00	2.33	1.74	2.84	2.54	2.49	2.14
Increase / (Decrease) in Invested Capital	0.00	2,043	-838	145	230	-134	238
Enterprise Value (EV)	0.00	0.00	2,404	2,692	2,661	3,821	2,599
Market Capitalization	0.00	0.00	1,165	2,020	1,982	3,222	1,881
Book Value per Share	$0.00	$0.00	$4.13	$15.36	$21.68	$20.65	$24.49
Tangible Book Value per Share	$0.00	$0.00	$1.36	$12.46	$18.34	$17.95	$21.60
Total Capital	0.00	2,138	1,580	1,710	1,860	1,651	1,819
Total Debt	0.00	26	1,398	1,032	959	804	853
Total Long-Term Debt	0.00	22	1,357	1,003	931	782	763
Net Debt	0.00	-69	1,239	672	679	599	718
Capital Expenditures (CapEx)	115	66	69	149	210	221	224
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	538	232	184	246	198	315
Debt-free Net Working Capital (DFNWC)	0.00	633	391	544	526	403	450
Net Working Capital (NWC)	0.00	629	350	515	498	381	360
Net Nonoperating Expense (NNE)	-6.76	-87	-105	268	23	29	26
Net Nonoperating Obligations (NNO)	0.00	-69	1,023	672	679	599	718
Total Depreciation and Amortization (D&A)	192	135	126	125	143	159	179
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	22.56%	8.20%	5.07%	6.61%	5.25%	9.40%
Debt-free Net Working Capital to Revenue	0.00%	26.54%	13.83%	14.99%	14.14%	10.68%	13.43%
Net Working Capital to Revenue	0.00%	26.37%	12.38%	14.20%	13.38%	10.10%	10.74%
Earnings Adjustments	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$7.53	$2.68	$6.02	$7.35	$3.29
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	43.96M	42.37M	41.22M	40.55M	39.51M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$7.53	$2.66	$5.93	$7.18	$3.24
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	43.96M	42.37M	41.22M	40.55M	39.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	43.96M	42.37M	41.22M	40.55M	39.51M
Normalized Net Operating Profit after Tax (NOPAT)	375	83	226	386	276	331	165
Normalized NOPAT Margin	9.33%	3.49%	8.00%	10.63%	7.43%	8.78%	4.93%
Pre Tax Income Margin	12.50%	3.98%	11.60%	12.87%	9.92%	10.73%	5.94%
Debt Service Ratios	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	7.77	11.85	11.38	6.10
NOPAT to Interest Expense	0.00	0.00	0.00	5.59	8.13	8.49	4.05
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	5.61	5.68	5.72	0.36
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	3.43	1.95	2.82	-1.70
Payout Ratios	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	8.47%	22.53%	20.53%	55.30%
Augmented Payout Ratio	0.00%	0.00%	0.00%	76.27%	50.20%	43.38%	117.42%

This table displays calculated financial ratios and metrics derived from Sylvamo's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	39,508,287.00	39,736,136.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	39,508,287.00	39,736,136.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-0.08	-0.28
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.99%	-3.83%	1.52%	7.58%	0.62%	-9.28%	-14.90%	-12.33%	-8.25%	-8.04%	1.51%
EBITDA Growth	-34.71%	-40.98%	37.07%	36.03%	36.04%	-24.07%	-52.83%	-21.08%	-24.50%	-46.34%	-26.67%
EBIT Growth	-47.48%	-53.38%	48.78%	46.00%	46.58%	-39.13%	-75.41%	-33.56%	-35.51%	-92.86%	-60.00%
NOPAT Growth	-46.75%	-51.43%	56.12%	64.86%	62.34%	-30.51%	-74.89%	-40.21%	-54.70%	-93.89%	-686.67%
Net Income Growth	-47.87%	-55.67%	69.39%	63.79%	65.31%	-37.21%	-81.93%	-40.00%	-59.26%	-111.11%	-173.33%
EPS Growth	-44.81%	-54.67%	73.68%	65.69%	63.25%	-36.27%	-81.31%	-37.89%	-57.59%	-112.31%	-175.68%
Operating Cash Flow Growth	17.61%	-57.14%	49.35%	-17.26%	-1.80%	-14.81%	-44.35%	-46.63%	-42.68%	-143.48%	-40.63%
Free Cash Flow Firm Growth	-294.77%	188.83%	182.26%	108.64%	224.95%	19.26%	-132.71%	-155.82%	-190.06%	-313.18%	-200.56%
Invested Capital Growth	17.04%	-1.69%	-10.63%	-1.64%	-8.48%	-3.56%	7.24%	8.75%	16.46%	12.67%	8.26%
Revenue Q/Q Growth	7.47%	-6.12%	3.09%	3.43%	0.52%	-15.36%	-3.29%	6.55%	5.20%	-15.17%	6.76%
EBITDA Q/Q Growth	-18.38%	-2.70%	47.22%	16.35%	-18.38%	-45.70%	-8.54%	94.67%	-21.92%	-61.40%	25.00%
EBIT Q/Q Growth	-27.00%	-5.48%	76.81%	19.67%	-26.71%	-60.75%	-28.57%	223.33%	-28.87%	-95.65%	300.00%
NOPAT Q/Q Growth	-16.24%	-7.38%	81.21%	17.26%	-17.52%	-60.35%	-34.52%	179.24%	-37.52%	-94.65%	-6,385.71%
Net Income Q/Q Growth	-15.52%	-12.24%	93.02%	14.46%	-14.74%	-66.67%	-44.44%	280.00%	-42.11%	-109.09%	-266.67%
EPS Q/Q Growth	-14.60%	-12.82%	94.12%	14.65%	-15.86%	-65.97%	-43.08%	281.08%	-42.55%	-109.88%	-250.00%
Operating Cash Flow Q/Q Growth	-15.23%	-83.83%	325.93%	41.74%	0.61%	-85.98%	178.26%	35.94%	8.05%	-110.64%	480.00%
Free Cash Flow Firm Q/Q Growth	88.36%	143.85%	253.27%	-52.09%	68.35%	-58.14%	-196.90%	18.25%	-171.61%	0.93%	-36.62%
Invested Capital Q/Q Growth	-0.06%	3.10%	-5.03%	0.52%	-7.01%	8.64%	5.60%	1.93%	-0.41%	5.11%	1.47%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	21.89%	20.88%	26.69%	27.46%	24.43%	19.37%	19.40%	26.24%	22.47%	16.56%	16.38%
EBITDA Margin	11.51%	11.93%	17.04%	19.17%	15.57%	9.99%	9.45%	17.26%	12.81%	5.83%	6.82%
Operating Margin	7.57%	7.62%	13.08%	15.13%	11.03%	5.12%	3.78%	11.47%	7.75%	0.40%	1.49%
EBIT Margin	7.57%	7.62%	13.08%	15.13%	11.03%	5.12%	3.78%	11.47%	7.75%	0.40%	1.49%
Profit (Net Income) Margin	5.08%	4.75%	8.90%	9.84%	8.35%	3.29%	1.89%	6.74%	3.71%	-0.40%	-1.36%
Tax Burden Percent	73.13%	71.67%	73.45%	71.97%	81.00%	81.82%	75.00%	64.77%	56.90%	50.00%	-1,100.00%
Interest Burden Percent	91.78%	86.96%	92.62%	90.41%	93.46%	78.57%	66.67%	90.72%	84.06%	-200.00%	8.33%
Effective Tax Rate	26.87%	28.33%	26.55%	28.03%	19.00%	18.18%	25.00%	35.23%	43.10%	0.00%	1,200.00%
Return on Invested Capital (ROIC)	14.07%	12.26%	21.68%	26.16%	22.28%	9.65%	6.28%	15.70%	9.45%	0.55%	-31.26%
ROIC Less NNEP Spread (ROIC-NNEP)	13.42%	11.45%	20.84%	24.68%	21.39%	8.60%	5.22%	14.82%	8.49%	-0.15%	-15.55%
Return on Net Nonoperating Assets (RNNOA)	11.48%	10.96%	19.54%	18.97%	15.64%	6.71%	4.13%	10.32%	6.17%	-0.12%	-12.52%
Return on Equity (ROE)	25.55%	23.22%	41.21%	45.13%	37.92%	16.37%	10.41%	26.02%	15.62%	0.43%	-43.78%
Cash Return on Invested Capital (CROIC)	3.16%	15.33%	26.86%	20.64%	30.74%	23.34%	8.52%	4.32%	-5.12%	-4.32%	-2.28%
Operating Return on Assets (OROA)	10.10%	10.04%	17.54%	20.19%	15.20%	6.96%	5.01%	14.14%	9.68%	0.48%	1.77%
Return on Assets (ROA)	6.78%	6.26%	11.94%	13.14%	11.51%	4.47%	2.50%	8.31%	4.63%	-0.48%	-1.62%
Return on Common Equity (ROCE)	25.55%	23.22%	41.21%	45.13%	37.92%	16.37%	10.41%	26.02%	15.62%	0.43%	-43.78%
Return on Equity Simple (ROE_SIMPLE)	0.00%	22.38%	28.07%	28.82%	0.00%	31.50%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	53	49	90	105	87	34	23	63	39	2.10	-132
NOPAT Margin	5.54%	5.46%	9.60%	10.89%	8.94%	4.19%	2.83%	7.43%	4.41%	0.28%	-16.38%
Net Nonoperating Expense Percent (NNEP)	0.65%	0.80%	0.83%	1.48%	0.89%	1.05%	1.06%	0.88%	0.95%	0.70%	-15.70%
Return On Investment Capital (ROIC_SIMPLE)	2.87%	-	-	-	5.25%	1.99%	1.27%	3.52%	2.16%	0.11%	-6.88%
Cost of Revenue to Revenue	78.11%	79.12%	73.31%	72.54%	75.57%	80.63%	80.60%	73.76%	77.53%	83.44%	83.62%
SG&A Expenses to Revenue	9.96%	8.18%	8.79%	7.67%	8.35%	8.89%	9.07%	8.04%	7.64%	9.67%	8.56%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	14.32%	13.26%	13.61%	12.33%	13.40%	14.25%	15.62%	14.78%	14.72%	16.16%	14.89%
Earnings before Interest and Taxes (EBIT)	73	69	122	146	107	42	30	97	69	3.00	12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	111	108	159	185	151	82	75	146	114	44	55
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.20	2.85	3.38	3.74	3.80	2.97	2.11	1.81	1.95	1.69	1.55
Price to Tangible Book Value (P/TBV)	2.60	3.36	3.95	4.31	4.38	3.42	2.43	2.08	2.21	1.92	1.78
Price to Revenue (P/Rev)	0.53	0.69	0.76	0.93	0.85	0.73	0.57	0.52	0.56	0.50	0.45
Price to Earnings (P/E)	7.84	12.74	12.03	12.97	10.67	9.44	9.28	9.82	14.25	16.19	19.54
Dividend Yield	2.20%	1.80%	1.69%	1.58%	1.91%	2.48%	3.62%	4.11%	3.77%	4.31%	4.82%
Earnings Yield	12.76%	7.85%	8.31%	7.71%	9.37%	10.60%	10.78%	10.18%	7.02%	6.18%	5.12%
Enterprise Value to Invested Capital (EV/IC)	1.68	2.01	2.27	2.65	2.64	2.14	1.64	1.47	1.54	1.38	1.30
Enterprise Value to Revenue (EV/Rev)	0.72	0.89	0.95	1.09	1.01	0.91	0.77	0.72	0.78	0.74	0.71
Enterprise Value to EBITDA (EV/EBITDA)	4.87	6.95	6.85	7.32	6.34	5.83	5.52	5.47	6.23	6.44	6.48
Enterprise Value to EBIT (EV/EBIT)	6.60	10.11	9.67	10.05	8.61	8.06	8.38	8.99	10.92	12.27	12.85
Enterprise Value to NOPAT (EV/NOPAT)	9.63	14.63	13.73	13.84	11.54	10.65	10.95	12.04	16.46	19.25	23.84
Enterprise Value to Operating Cash Flow (EV/OCF)	5.28	7.00	6.95	8.73	8.15	7.23	6.58	7.34	9.70	10.39	11.13
Enterprise Value to Free Cash Flow (EV/FCFF)	57.47	13.00	7.99	12.73	8.22	9.00	19.93	35.38	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.06	1.07	1.11	0.99	0.95	0.90	0.85	0.83	0.88	0.94	1.01
Long-Term Debt to Equity	1.03	1.04	1.08	0.94	0.92	0.87	0.80	0.80	0.79	0.78	0.88
Financial Leverage	0.86	0.96	0.94	0.77	0.73	0.78	0.79	0.70	0.73	0.77	0.81
Leverage Ratio	3.54	3.33	3.26	3.18	3.13	3.02	3.00	2.91	2.96	2.90	2.90
Compound Leverage Factor	3.24	2.90	3.02	2.88	2.93	2.37	2.00	2.64	2.49	-5.79	0.24
Debt to Total Capital	51.56%	51.63%	52.63%	49.70%	48.70%	47.36%	45.88%	45.27%	46.89%	48.47%	50.23%
Short-Term Debt to Total Capital	1.51%	1.52%	1.60%	2.31%	1.33%	1.33%	2.60%	1.68%	4.95%	8.16%	6.31%
Long-Term Debt to Total Capital	50.05%	50.11%	51.03%	47.40%	47.37%	46.03%	43.28%	43.59%	41.95%	40.32%	43.93%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	48.44%	48.37%	47.37%	50.30%	51.30%	52.64%	54.12%	54.73%	53.11%	51.53%	49.77%
Debt to EBITDA	1.76	2.01	1.79	1.64	1.33	1.42	1.65	1.78	2.05	2.43	2.69
Net Debt to EBITDA	1.24	1.57	1.39	1.10	0.99	1.15	1.42	1.57	1.72	2.09	2.34
Long-Term Debt to EBITDA	1.71	1.96	1.74	1.57	1.30	1.38	1.56	1.71	1.83	2.02	2.35
Debt to NOPAT	3.47	4.24	3.60	3.11	2.43	2.59	3.27	3.92	5.40	7.26	9.88
Net Debt to NOPAT	2.46	3.31	2.80	2.08	1.81	2.10	2.82	3.46	4.55	6.24	8.62
Long-Term Debt to NOPAT	3.37	4.11	3.49	2.97	2.36	2.52	3.09	3.77	4.83	6.04	8.64
Altman Z-Score	3.27	3.52	3.83	3.96	4.18	3.89	3.52	3.45	3.35	3.07	2.97
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.72	1.72	1.68	1.72	1.56	1.64	1.54	1.52	1.50	1.45	1.47
Quick Ratio	0.93	0.87	0.85	0.96	0.93	0.93	0.78	0.75	0.78	0.67	0.65
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-177	77	274	131	221	92	-90	-73	-199	-197	-269
Operating Cash Flow to CapEx	265.08%	45.00%	216.98%	370.45%	256.25%	47.92%	96.97%	161.11%	167.86%	-20.41%	62.30%
Free Cash Flow to Firm to Interest Expense	-29.44	8.61	30.40	9.36	31.52	10.26	-8.95	-8.13	-18.07	-21.88	-24.45
Operating Cash Flow to Interest Expense	27.83	3.00	12.78	11.64	23.43	2.56	6.40	9.67	8.55	-1.11	3.45
Operating Cash Flow Less CapEx to Interest Expense	17.33	-3.67	6.89	8.50	14.29	-2.78	-0.20	3.67	3.45	-6.56	-2.09
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.33	1.32	1.34	1.33	1.38	1.36	1.32	1.23	1.25	1.20	1.19
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	7.32	6.25	6.28	6.51	7.41	7.13	6.77	6.22	6.72	6.04	5.82
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	6.43	7.02	7.23	7.48	7.12	7.04	7.20	6.96	6.92	6.52	6.60
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	49.90	58.36	58.16	56.10	49.28	51.16	53.92	58.68	54.35	60.39	62.67
Days Payable Outstanding (DPO)	56.78	51.97	50.51	48.81	51.28	51.88	50.71	52.44	52.74	56.01	55.28
Cash Conversion Cycle (CCC)	-6.89	6.39	7.64	7.29	-2.00	-0.72	3.20	6.25	1.60	4.38	7.39
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,580	1,629	1,547	1,555	1,446	1,571	1,659	1,691	1,684	1,770	1,796
Invested Capital Turnover	2.54	2.24	2.26	2.40	2.49	2.31	2.21	2.11	2.14	1.97	1.91
Increase / (Decrease) in Invested Capital	230	-28	-184	-26	-134	-58	112	136	238	199	137
Enterprise Value (EV)	2,661	3,276	3,519	4,119	3,821	3,361	2,722	2,481	2,599	2,442	2,326
Market Capitalization	1,982	2,536	2,802	3,501	3,222	2,698	2,022	1,767	1,881	1,651	1,485
Book Value per Share	$21.68	$21.62	$20.18	$22.85	$20.65	$22.39	$23.55	$24.20	$24.49	$24.78	$24.03
Tangible Book Value per Share	$18.34	$18.36	$17.24	$19.80	$17.95	$19.46	$20.46	$21.03	$21.60	$21.72	$20.99
Total Capital	1,860	1,838	1,752	1,863	1,651	1,725	1,772	1,785	1,819	1,900	1,919
Total Debt	959	949	922	926	804	817	813	808	853	921	964
Total Long-Term Debt	931	921	894	883	782	794	767	778	763	766	843
Net Debt	679	740	717	618	599	663	700	714	718	791	841
Capital Expenditures (CapEx)	63	60	53	44	64	48	66	54	56	49	61
Debt-free, Cash-free Net Working Capital (DFCFNWC)	246	285	269	250	198	264	275	273	315	364	353
Debt-free Net Working Capital (DFNWC)	526	494	474	558	403	418	388	367	450	494	476
Net Working Capital (NWC)	498	466	446	515	381	395	342	337	360	339	355
Net Nonoperating Expense (NNE)	4.39	6.45	6.61	10	5.67	7.36	7.50	5.83	6.26	5.10	-121
Net Nonoperating Obligations (NNO)	679	740	717	618	599	663	700	714	718	791	841
Total Depreciation and Amortization (D&A)	38	39	37	39	44	40	45	49	45	41	43
Debt-free, Cash-free Net Working Capital to Revenue	6.61%	7.73%	7.27%	6.64%	5.25%	7.16%	7.75%	7.96%	9.40%	11.08%	10.71%
Debt-free Net Working Capital to Revenue	14.14%	13.41%	12.81%	14.81%	10.68%	11.33%	10.93%	10.70%	13.43%	15.04%	14.44%
Net Working Capital to Revenue	13.38%	12.65%	12.06%	13.67%	10.10%	10.71%	9.63%	9.82%	10.74%	10.32%	10.77%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.19	$1.04	$2.02	$2.32	$1.97	$0.66	$0.37	$1.43	$0.83	($0.08)	($0.28)
Adjusted Weighted Average Basic Shares Outstanding	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M	39.76M
Adjusted Diluted Earnings per Share	$1.17	$1.02	$1.98	$2.27	$1.91	$0.65	$0.37	$1.41	$0.81	($0.08)	($0.28)
Adjusted Weighted Average Diluted Shares Outstanding	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M	39.76M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	41.22M	41.13M	41.00M	41.01M	40.55M	40.72M	40.37M	39.44M	39.51M	39.74M	39.76M
Normalized Net Operating Profit after Tax (NOPAT)	53	49	90	105	87	34	23	63	39	2.10	8.40
Normalized NOPAT Margin	5.54%	5.46%	9.60%	10.89%	8.94%	4.19%	2.83%	7.43%	4.41%	0.28%	1.04%
Pre Tax Income Margin	6.95%	6.63%	12.11%	13.68%	10.31%	4.02%	2.52%	10.40%	6.52%	-0.79%	0.12%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.17	7.67	13.56	10.43	15.29	4.67	3.00	10.78	6.27	0.33	1.09
NOPAT to Interest Expense	8.90	5.49	9.96	7.51	12.38	3.82	2.25	6.98	3.57	0.23	-12.00
EBIT Less CapEx to Interest Expense	1.67	1.00	7.67	7.29	6.14	-0.67	-3.60	4.78	1.18	-5.11	-4.45
NOPAT Less CapEx to Interest Expense	-1.60	-1.17	4.07	4.36	3.24	-1.52	-4.35	0.98	-1.52	-5.21	-17.55
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	22.53%	29.65%	26.18%	25.19%	20.53%	23.78%	33.49%	41.11%	55.30%	71.57%	96.05%
Augmented Payout Ratio	50.20%	62.31%	51.93%	42.59%	43.38%	53.15%	69.72%	108.33%	117.42%	132.35%	151.32%

Financials Breakdown Chart

Key Financial Trends

Sylvamo’s latest quarter shows a sharp drop in profitability and weaker cash generation compared with both the prior quarter and the year-ago period. In Q1 2026, revenue fell to $755 million from $890 million in Q4 2025 and $821 million in Q1 2025, while the company posted a $3 million net loss. That compares with $33 million of net income in Q4 2025 and $27 million in Q1 2025.

Margin pressure was the biggest issue. Gross profit declined to $125 million, and operating income nearly broke even at just $3 million. Interest expense of $9 million pushed the company to a $6 million pre-tax loss, and after taxes Sylvamo reported a $3 million net loss, or $(0.08) per share.

Cash flow also weakened materially. Sylvamo used $10 million of cash in operating activities in Q1 2026, versus positive operating cash flow of $94 million in Q4 2025 and $23 million in Q1 2025. Capital spending was still elevated at $49 million, and after financing and investing activities cash and equivalents fell by $5 million during the quarter.

The balance sheet remains manageable, but leverage is still meaningful. At March 31, 2026, Sylvamo held $130 million of cash and $1.855 billion of total liabilities against $979 million of equity. Total debt was $921 million, down from $1.097 billion at the end of Q4 2025, but still a notable burden relative to equity and earnings power.

There are a few positives in the latest data set. The company reduced debt during the quarter, and inventories were lower than the prior-year period. Retained earnings also remain strong, suggesting the business has produced substantial cumulative profits over time despite near-term volatility.

Debt levels declined in Q1 2026, with total debt falling to $921 million from $1.097 billion at year-end 2025.
Revenue remains substantial at $755 million, showing Sylvamo still has a large operating base.
Inventory was lower year over year, which may indicate some improvement in working capital management.
Retained earnings remain high at $2.493 billion, reflecting the company’s accumulated profitability over time.
Cash and equivalents totaled $130 million at quarter-end, providing some liquidity cushion.
The company continued paying dividends at $0.45 per share, signaling an ongoing shareholder-return policy.
Q1 2026 ended with a net loss of $3 million, a clear step down from prior profitable quarters.
Operating cash flow turned negative to $(10) million, compared with positive cash generation in the prior quarter and year-ago period.
Revenue declined 15% sequentially from Q4 2025 and about 8% from Q1 2025.
Long-term debt remained elevated at $766 million, keeping interest expense a drag on earnings.

Overall, Sylvamo’s trend looks mixed to weak heading into 2026. The company is still generating meaningful revenue, but lower sales, thin operating margins, negative operating cash flow, and continued debt costs suggest investors should watch for evidence of demand stabilization and stronger pricing before expecting a sustained recovery.

08/25/26 01:03 PM ETAI Generated. May Contain Errors.

Sylvamo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Sylvamo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Sylvamo's net income appears to be on a downward trend, with a most recent value of $132 million in 2025, falling from $377 million in 2019. The previous period was $302 million in 2024. View Sylvamo's forecast to see where analysts expect Sylvamo to go next.

Sylvamo's total operating income in 2025 was $238 million, based on the following breakdown:

Total Gross Profit: $735 million
Total Operating Expenses: $497 million

Over the last 6 years, Sylvamo's total revenue changed from $4.02 billion in 2019 to $3.35 billion in 2025, a change of -16.6%.

Sylvamo's total liabilities were at $1.80 billion at the end of 2025, a 2.3% increase from 2024, and a 124.9% increase since 2020.

In the past 5 years, Sylvamo's cash and equivalents has ranged from $95 million in 2020 to $360 million in 2022, and is currently $135 million as of their latest financial filing in 2025.

Over the last 6 years, Sylvamo's book value per share changed from 0.00 in 2019 to 24.49 in 2025, a change of 2,449.4%.

Related Companies

Financial statements for NYSE:SLVM last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sylvamo (SLVM) Financials

Financials Breakdown Chart

Key Financial Trends

Sylvamo Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sylvamo (SLVM) Financials

Annual Income Statements for Sylvamo

Quarterly Income Statements for Sylvamo

Annual Cash Flow Statements for Sylvamo

Quarterly Cash Flow Statements for Sylvamo

Annual Balance Sheets for Sylvamo

Quarterly Balance Sheets for Sylvamo

Annual Metrics And Ratios for Sylvamo

Quarterly Metrics And Ratios for Sylvamo

Financials Breakdown Chart

Key Financial Trends

Sylvamo Financials - Frequently Asked Questions

When does Sylvamo's fiscal year end?

How has Sylvamo's net income changed over the last 6 years?

What is Sylvamo's operating income?

How has Sylvamo's revenue changed over the last 6 years?

How much debt does Sylvamo have?

How much cash does Sylvamo have?

How has Sylvamo's book value per share changed over the last 6 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools